Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 0.52% | 130.40 | 0.0% | $2978.05m | |
| BNGO | BioNano Genomics, Inc. | 21.01% | 8.41 | 0.0% | $1423.93m | |
| GILD | Gilead Sciences, Inc. | 0.40% | 62.65 | 1.0% | $653.98m | |
| AMGN | Amgen, Inc. | -0.10% | 241.43 | 1.3% | $585.17m | |
| CRSP | CRISPR Therapeutics AG | 1.40% | 212.97 | 0.6% | $547.40m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.41% | 157.29 | 2.0% | $544.88m | |
| NVAX | Novavax, Inc. | 1.42% | 131.82 | 92.9% | $502.25m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.65% | 521.29 | 2.7% | $484.53m | |
| ILMN | Illumina, Inc. | 2.82% | 381.49 | 3.5% | $368.67m | |
| BIIB | Biogen, Inc. | 0.54% | 281.80 | 1.7% | $365.87m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.01% | 226.09 | 1.9% | $344.39m | |
| BNTX | BioNTech SE | -2.21% | 103.51 | 0.0% | $330.70m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.61% | 91.35 | 13.8% | $288.18m | |
| OCGN | Ocugen, Inc. | 6.45% | 2.32 | 0.0% | $287.47m | |
| EXAS | EXACT Sciences Corp. | 1.17% | 149.01 | 19.6% | $256.12m |
Company Profile
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research & Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.